UNDISCLOSED
Exclusive Financial Advisor and Placement Agent
Merger with Cartesian Therapeutics and Concurrent Private Financing
November 2023
$200 Million
Joint Bookrunner
Follow-On
November 2023
$150 Million
Joint Bookrunner
Follow-On
November 2023
$99 Million
Joint Bookrunner
Follow-On
November 2023
$100 Million
Joint Bookrunner
Initial Public Offering
November 2023
$30 Million
Global Coordinator and Joint Bookrunner
Follow-On
November 2023
$236 Million
Joint Global Coordinator and Bookrunner
U.S. Initial Public Offering
October 2023
$225 Million
Joint Bookrunner
Follow-On
October 2023
$300 Million
Joint Placement Agent
PIPE
September 2023
$450 Million
Joint Bookrunner
Common Stock Financing
September 2023
UNDISCLOSED
Lead Financial Advisor
Sale to Azurity Pharmaceuticals, a Portfolio Company of QHP Capital
September 2023
$100 Million
Joint Bookrunner
Follow-On
September 2023